Matches in Wikidata for { <http://www.wikidata.org/entity/Q93161004> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q93161004 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q93161004 description "scientific article published on 06 September 2019" @default.
- Q93161004 description "wetenschappelijk artikel" @default.
- Q93161004 description "наукова стаття, опублікована 6 вересня 2019" @default.
- Q93161004 name "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 name "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 type Item @default.
- Q93161004 label "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 label "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 prefLabel "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 prefLabel "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 P1433 Q93161004-83C654E0-AD4C-4969-9BD3-B04E5F6E5D13 @default.
- Q93161004 P1476 Q93161004-E2FF25BD-B443-4565-B14D-105E82F49213 @default.
- Q93161004 P2093 Q93161004-091D8692-C8B4-4852-9841-4D3074BDAF0C @default.
- Q93161004 P2093 Q93161004-2504100B-98E1-4574-A2E9-21BC84E4AC1B @default.
- Q93161004 P2093 Q93161004-553850BD-F7D5-4617-AC32-869266B51CD6 @default.
- Q93161004 P2093 Q93161004-7FDBB205-65EE-4016-8C8A-EE56EB04E291 @default.
- Q93161004 P2093 Q93161004-AD0A7ECA-FFCB-432A-B252-9C9EAAE3F9FC @default.
- Q93161004 P2093 Q93161004-BCB8D1D4-6F84-4E08-BF4C-B72F81F05BB5 @default.
- Q93161004 P2093 Q93161004-DCC1ABCF-1F36-48F5-AA15-F0589C656756 @default.
- Q93161004 P2860 Q93161004-72754AED-23D8-4361-A8AE-8D919ED455B8 @default.
- Q93161004 P2860 Q93161004-C812FC9A-57C0-4C44-B904-D12C1ABEF8F9 @default.
- Q93161004 P304 Q93161004-3581D8D5-1DC8-4920-B168-A6F006D95699 @default.
- Q93161004 P31 Q93161004-E8513A7D-AFE0-415B-BA86-596EDB771753 @default.
- Q93161004 P356 Q93161004-3B97573C-85F2-4251-B402-496419F584AF @default.
- Q93161004 P433 Q93161004-474767F2-043C-49B4-AB4A-39AE71B8E7CF @default.
- Q93161004 P478 Q93161004-525200CD-C5B1-4732-9169-F1E72534D38B @default.
- Q93161004 P50 Q93161004-9B6C71E2-6219-4D0C-BE83-846402EAB624 @default.
- Q93161004 P577 Q93161004-E69665DE-E731-4767-9739-8419D42EAEBF @default.
- Q93161004 P698 Q93161004-99D2CDB2-1ED8-4AEC-B448-E0A1E066A299 @default.
- Q93161004 P921 Q93161004-5943461C-1A14-45B4-8D62-92AC9C92C5C3 @default.
- Q93161004 P921 Q93161004-C42E1DC8-ADA7-4152-9E10-D0EF840762E7 @default.
- Q93161004 P921 Q93161004-D790B0C4-8D43-41B7-84D3-BD368DDB6B26 @default.
- Q93161004 P921 Q93161004-DBBFDC60-3420-4F7C-9811-8DD3C5A93EA8 @default.
- Q93161004 P356 WNL.0000000000008239 @default.
- Q93161004 P698 31492718 @default.
- Q93161004 P1433 Q1161692 @default.
- Q93161004 P1476 "Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial" @default.
- Q93161004 P2093 "Jonathan Rabinowitz" @default.
- Q93161004 P2093 "Ladostigil Study Group" @default.
- Q93161004 P2093 "Marta Weinstock" @default.
- Q93161004 P2093 "Reinhold Schmidt" @default.
- Q93161004 P2093 "Ronald G Thomas" @default.
- Q93161004 P2093 "Stefan Ropele" @default.
- Q93161004 P2093 "Yona Geffen" @default.
- Q93161004 P2860 Q29615078 @default.
- Q93161004 P2860 Q39512850 @default.
- Q93161004 P304 "e1474-e1484" @default.
- Q93161004 P31 Q13442814 @default.
- Q93161004 P356 "10.1212/WNL.0000000000008239" @default.
- Q93161004 P433 "15" @default.
- Q93161004 P478 "93" @default.
- Q93161004 P50 Q93160997 @default.
- Q93161004 P577 "2019-09-06T00:00:00Z" @default.
- Q93161004 P698 "31492718" @default.
- Q93161004 P921 Q1472703 @default.
- Q93161004 P921 Q269829 @default.
- Q93161004 P921 Q42824440 @default.
- Q93161004 P921 Q57859955 @default.